Search

everythinglearnresearchcommunity

for

Search:↓

ARWH is a rare hair disorder with no cure, but potential treatments include minoxidil and other therapies.

A 4-year-old girl with a rare lupus condition was successfully treated with oral corticosteroids, leading to full recovery and hair regrowth.

rwSALT provides precise hair regrowth measurement from scalp photos.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

A rare genetic disease causes sparse hair and early blindness due to a gene mutation.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

The mutation causes hairless mice due to mislocalized and dysfunctional HR protein.

Researchers made a detailed map of gene activity for different parts of human hair follicles to help create targeted hair disorder treatments.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Keratins are crucial for cell stability, wound healing, and cancer diagnosis.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Understanding developmental pathways can improve wound healing treatments.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Rosacea is a skin condition with unclear causes, classified into four subtypes.